Streetbeat News

Stock Prices

HALO

Halozyme Therapeutics (NASDAQ:HALO) reported Q2 earnings of $0.91 per share, beating the analyst estimate of $0.78 by 16.67%. Sales were $231.35M, surpassing the $208.90M estimate by 10.75%. Both earnings and sales showed year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 8:02 pm

GO

Grocery Outlet Holding (NASDAQ:GO) reported Q2 2024 adjusted EPS of $0.25, beating the $0.20 estimate. Sales were $1.13 billion, surpassing the $1.10 billion estimate and marking an 11.88% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 8:01 pm

HIMS

Analysts have provided mixed ratings for Hims & Hers Health (NYSE:HIMS) over the past three months, with a notable increase in the average 12-month price target from $16.81 to $22.11. The company has shown strong financial performance, including a 45.81% revenue growth rate and a net margin of 4.0%.

Portfolio Pulse from Benzinga Insights

August 06, 2024 | 8:01 pm

JACK

Jack In The Box (NASDAQ:JACK) reported Q3 earnings of $1.65 per share, beating the estimate of $1.51. However, sales of $369.17M missed the $371.11M estimate. Earnings increased by 13.79% YoY, while sales decreased by 7.00% YoY.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 8:01 pm

GOVX

Geovax Labs (NASDAQ:GOVX) reported a Q2 2024 GAAP EPS of $(1.99), beating the analyst consensus estimate of $(3.37) by 40.95%. The company also reported $301,000 in sales for the quarter.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 8:01 pm

RXST

RxSight (NASDAQ:RXST) has received mixed analyst ratings, with 4 bullish and 2 somewhat bullish ratings in the last 30 days. Analysts have lowered their average 12-month price target by 11.81%, now averaging $63.5. The company's financials show strong revenue growth but weak profitability metrics.

Portfolio Pulse from Benzinga Insights

August 06, 2024 | 8:01 pm

KO

Deep-pocketed investors have shown a bearish trend towards Coca-Cola (NYSE:KO) based on recent options activity. Benzinga's options scanner highlighted 10 significant options trades, with 60% of the sentiment being bearish. The major market movers are focusing on a price range between $65.0 and $80.0 for KO. Analysts have mixed ratings, with target prices ranging from $65 to $75.

Portfolio Pulse from Benzinga Insights

August 06, 2024 | 8:01 pm

IREN

Recent options trading activity for Iris Energy (NASDAQ:IREN) indicates a mixed sentiment among big-money investors, with a notable volume of both bullish and bearish trades. Analysts have provided varied price targets, reflecting differing outlooks on the stock's future performance.

Portfolio Pulse from Benzinga Insights

August 06, 2024 | 8:01 pm

HRMY

Analysts have mixed views on Harmony Biosciences (NASDAQ:HRMY) with 4 analysts rating it bullish over the past three months. The average 12-month price target is $51.0, slightly down from $52.0. The company shows strong financial performance with significant revenue growth, high net margin, and effective debt management.

Portfolio Pulse from Benzinga Insights

August 06, 2024 | 8:01 pm

CBRL

In the last three months, 8 analysts have published ratings on Cracker Barrel Old (NASDAQ:CBRL), showing a negative shift in sentiment. The average 12-month price target has decreased by 16.18% to $50.5. Analysts have lowered their ratings and price targets, reflecting concerns over the company's financial performance, including a decline in revenue and profitability metrics.

Portfolio Pulse from Benzinga Insights

August 06, 2024 | 8:00 pm